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ABSTRACT 
Effect of the extent of motor seizure modification on cardiovascular responses in ECT was 
studied at the second ECT session in 50 (ULECT=25) consenting patients. Twenty five patients 
each received either 0.5 mg/kg or 1 mg/kg of succinylcholine in a random design. Blood pressure 
and heart rate were recorded on five occasions during the ECT session. Extent of motor seizure 
was assessed on a five point scale by two raters blind to succinylcholine dose. Two raters had good 
interrater agreement on the scale. Significantly more patients had poor modification with 0.5 mg/kg 
(68%) than with 1 mg/kg (12%) of succinylcholine. Rate-pressure-product (RPP=systolic BPx Heart 
rate) significantly changed over the five occasions, maximal being in ictal occasion, but the two 
succinylcholine dose groups did not differ. Ictal RPP positively correlated with post-anaesthesia 
RPP, ECT stimulus dose, seizure threshold and both seizure durations (Motor and EEG). Likewise, 
postictal RPP correlated with seizure threshold and actual ECT stimulus dose. Neither correlated 
with the motor seizure modification scores. In multiple, stepwise, linear regression models neither 
ictal nor post-ictal RPP variance was significantly explained by the extent of motor seizure modification 
scores. Hence, RPP changes during ECT may be reflecting cerebral mechanisms of ECT. 
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Electroconvulsive therapy (ECT) induces 
a prompt (acute) cardiovascular (CV) response. 
Electrical stimulus of the ECT and seizures 
induced by it produce marked cardiovascular 
responses by direct stimulation of cardiac centres 
in hypothalamus and indirectly by the 
generalization of seizure (Abrams,1997). The 
acute CV responses in an unatropinised 
individual are an initial asystole followed by a 
transient tachycardia and increased blood 
pressure. Blood pressure (BP) responses 
generally parallel heart rate throughout the 
treatment. The BP drops sharply during the initial 
vagal, hypertonic phase and then rapidly 
increases upto 40% over baseline. The BP 
elevation is more when atropine premedication 
motor seizure modification, succinylcholine dose. 
is given (Mu'lgaokar et al.,1985; Prudic et 
al.,1987). More specifically, systolic blood 
pressure peaks during immediate poststimulus 
(ictal) period. These increase in systolic blood 
pressure is greater than diastolic blood pressure 
(Prudic et al.,1987). 
Rate-Pressure-Product(RPP), a product 
of heart rate and systolic blood pressure, is an 
index of myocardial oxygen consumption and is 
one such measure of CV response during ECT. 
RPP change during ECT have been described 
(Mayur et al.,1998a; Webb et al.,1990). RPP 
increase by 30% to 140% during ECT induced 
seizure (Jones & Knight et al.,1981; Mulgaokar 
et al.,1985; Huang etal.,1989; Webb et al.,1990). 
It reaches its maximum about 30 seconds after 
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the ECT stimulus (Jones & Knight, 1981). Use 
of atropine as premedication during ECT 
increase RPP response (Mayur et al.,1998b). 
Postical RPP was significantly higher after 
threshold BLECT than threshold ULECT (Mayur 
etal., 1998a). However, unilateral threshold ECT 
produced significantly lower RPP than unilateral 
suprathreshold and bilateral suprathreshold ECT 
conditions within the same group of patients 
(Gangadhar etal., 1999). 
Succinylcholine is a muscle relaxant, 
commonly used in ECT. By its depolarising 
properties it increases serum potassium levels 
and variably modifies peripheral motor 
convulsions. These factors can affect 
cardiovascular responses both directly and 
indirectly. It is likely that a more pronounced 
convulsive response contribuios to higher RPP, 
which was examined in this study. 
MATERIAL AND METHOD 
Patients : 
Consenting consecutive patients referred 
for ECT (n=50; 31 males; Unilateral=25, 
Bilateral=25) formed the sample. Their mean ± 
SD age was 27.92±9.9 years and mean ± SD 
body weight 49.25±10.65 kilograms. Their 
diagnoses were schizophrenia (n=27), mania 
(n=4) and depression (n=19). After obtaining 
additional consent for this trial, they were part of 
the study at the second ECT session. All patients 
were right handed and continued to receive one 
or more psychotropic drugs, not lithium. None 
had cardiovascular clinical abnormalities or liver 
dysfunction (supported by biochemical liver 
function tests). 
Anesthesia : 
Patients were anesthetised with 
thiopentone (4 mg/kg) and atropine (0.65 mg). 
During the second ECT session, they were 
equally randomized to receive either 0.5 mg/kg 
or 1.0 mg/kg body weight of succinylcholine. 
Intermittent positive pressure ventilation with 
100% oxygen was provided till resumption of 
spontaneous and regular breathing. 
r & MOTOR SEIZURE MODIFICATION 
ECT administration : 
ECT was administered using a 
computerized constant current (800mA) 
bidirectional brief pulse (1.25 msec width) device 
(NIVIQURE) with EFG monitoring (F3 & F4 
referenced to linked mastoids). The ECT 
machine provides pulses at a rate of 125 pps. 
The total stimulus dose (mC) is adjusted by 
setting the stimulus train length (0.2-3.6s). The 
stimulus laterality was as prescribed by the 
referring psychiatrist. Standard bifrontotemporal 
and nondominant (right) D'Elia stimulus 
electrode positions were used for bilateral 
(BLECT) and right unilateral (ULECT) ECT 
patients respectively. ULECT patients received 
2.5 times threshold stimulus and BLECT patients 
received 60 mC above the threshold. Motor 
seizure was monitored with the cuff above the 
right ankle. Last clonic movement on any part 
of the body was considered the end of motor 
seizure and unequivocal absence of epileptiform 
transients for more than five seconds on both 
channels was considered as the end of the EEG 
seizure (Gangadhar et al.,1995). 
Cardiovascular monitoring : 
Online cardiovascular and pulse oximetric 
parameters were monitored using Cardiocap-ll. 
Blood pressure and heart rate were recorded 
before and after induction of anesthesia, 20 
seconds poststimulus (ictal), postical and after 
spontaneous resumption of respiration. 
Assessments : 
One independent investigator (MN) was 
responsible for recruiting and randomising 
patients to two different doses of succinylcholine. 
The anaesthetist (Rater - A; SKS) and one other 
psychiatrist (Rater - B; SESM) who were unaware 
of the dose of succinylcholine, independently 
rated the extent of motor seizure modification 
using a standardized scale (Appendix). A score 
of less than three and 3 or more on the scale 
were operationally defined as poor' and good' 
modifications respectively Rater-B noted the 
motor and EEG seizure durations using the 
digital counter in the ECT machine. Two milliliters 
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of blood was drawn from the patients before the 
administra'tion of anesthetic agents and 
immediately after ECT for the estimation of the 
serum potassium levels. Serum potassium 
assays on coded samples were performed 
without knowledge of patient data(RC). 
Statistics : 
Independent sample t-test and chi-square 
test were used to compare variables of patients 
with' low dose' (0.5 mg/kg) and 'high dose' (1mg/ 
kg). Change in serum potassium levels from pre-
to post- ECT occasions was examined using 
paired t-test. Interrater reliability on the 
modification score between raters (Rater-A and 
Rater-B) was assessed using Kappa correlation. 
For further analyses, scores by the psychiatrist 
(Rater-B) were used. Two way repeated measure 
analysis of variance (RMANOVA) was used to 
examine the change of RPP across five 
occasions (within-subject factor) with 'poor'/ 
'good' modification as between-subject factor. 
RMANOVA was repeated with succinylcholine 
dose and with laterality as between-subject 
factors separately. Pearson's correlation was 
applied to determine factors influencing RPP in 
each of the five occasions. Multiple, step-wise, 
linear regression was used to determine the 
factors influencing ictal and postictal RPP for 
entire patient sample. The probability (alpha) was 
fixed at <0.05. 
Results : 
Socio-demographic and ECT variables 
were comparable between patients who received 
low
1 and high' dose succinylcholine (Table-1). 
The two raters showed good agreement for the 
scores of extent of modification (Kappa 
Coefficients.88) as well as for recorded scores 
of 'good' and poor modification (Kappa 
Coefficients.91) respectively. The modification 
score was higher in the 1 mg/kg group. Also only 
3 (12%) patients in this group had 'poor' 
modification as against 17 (68%) of the 0.5 
mg/kg group. Serum potassium levels 
(mean±SD meq/L) significantly rose from pre-
(4.34±0.2) to post- (4.58±0.3) ictal occasion in 
the patients with succinylcholine of 1 mg/kg (t=4, 
df=23, p=0.001). No such changes were noted 
in the ECT session with 0.5 mg/kg (pre=4.53±0.3; 
post=4.57±0.3 : t=0.57, df=23, p=0.57). 
RPP changed significantly over the five 
occasions, being highest in ictal recording 
(Table.2). Neither, succinylcholine dose, nor 
stimulus laterality, nor extent of modification 
(as between-subject factors) affected RPP 
differentially (Table.2). Ictal RPP positively 
correlated with post-anaesthesia RPP, ECT 
stimulus dose, and seizure threshold, seizure 
durations (both motor and EEG) but did not 
correlate with motor seizure modification scores. 
Likewise, postictal RPP correlated with threshold 
and actual ECT stimulus dose but not with motor 
seizure modification scores. (Table.3). 
In view of multiple correlations, ictal and 
postictal RPP as dependent variables, were 
examined in two separate multiple, stepwise, 
linear regression models. Age, threshold, actual 
TABLE 1 
COMPARISON OF VARIABLES (MEAN+SD, "NUMBER) ACROSS LOW AND 
HIGH DOSE SUCCINYLCHOLINE PATIENTS GROUPS 
Subjects -> 
Variable J 
Age(years) 
Gender M:F* 
BLECTULECT* 
ECT stimulus dose (mC) 
EEG seizure duration in (s) 
Motor seizure duration in (s) 
' Extent of motor seizure 
modification on five point scale 
Poor :Good modification 
low'dose 
(0.5mg/kg)(n=25) 
27.2±96 
15:10 
12:13 
139.2±58.6 
66.52±26.3 
58.1±22.2 
2.4±0.7 
14:11 
'high'dose 
(1 mg/kg) (n=25) 
29.2±10.2 
16:9 
13:12 
151 2±49.4 
63.1 ±25.7 
50.8±22.7 
332±085 
3:22 
T/x
2, df, p 
0.68,48,0.50 
0.08, 1,0.77 
0.08, 1, 77 
0 78,48,0 44 
0.48,48,0.64 
1.14,48,0.26 
4.15,48,0.001 
10.7, 1,0.001 
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TABLE 2 
COMPARISON OF MEAN±SD RPP VALUES ACROSS DIFFERENT GROUPS 
Occasion -> 
Group I 
Succinylcholine 
0.5mg/kg (n=25) 
1mg/kg(n=25) 
Laterality 
ULECT (n=25) 
BLECT(n=25) 
Modification 
'poor' (n=20) 
'Good' (n=30) 
Pre-
anaesthesia 
12253 
±3584 
11338 
±2272 
11939 
±3046 
11652 
±3020 
12203 
±1877 
11004 
±3401 
Post-
anaesthesia 
13814 
±2468 
13504 
±2370 
13242 
±2170 
14075 
±2586 
13666 
±1962 
13646 
±2662 
Ictal 
17700 
±4064 
17953 
±4735 
18971 
±5062 
16683 
±3259 
18020 
±4485 
17452 
±4365 
Post-
ictal 
13649 
±3156 
15318 
±2977 
15089 
±3397 
13878 
±2824 
14140 
±2816 
15151 
±3299 
Post- RR 
recovery 
14248 
±4012 
14983 
±2651 
14620 
±3419 
14611 
±3429 
14791 
±2197 
14275 
±3879 
Two-way 
RMANOVA 
F; df; p 
F,=0.18;48, 1;0.64 
F2=0.12;4;0.19 
F3=0.64; 4; 0.001 
F,=0.78;48;1;0.38 
F2=0.19;4;0.03 
F3=0.68; 4; 0.001 
F,=0.13;48;1;0.71 
F2=0.11;4; 0.24 
F3=0.65; 4; 0.001 
F,=Group effect; F2=lnteraction effect; F3=Occasion effect; RR-Respiratory recovery 
TABLE 3 
PEARSON'S CORRELATION MATRIX, (VALUES REFER TO "r" VALUES; 
TWO TAILED SIGNIFICANCE "p<0.01, * 'p^.OS) 
RPP post 
anaesthesia 
RPP 
ictal 
RPP 
postictal 
Seizure 
'threshold 
ECT actual 
stimulus dose 
Motor seizure 
duration 
EEG seizure 
duration 
Motor seizure 
modification 
score 
age 
RPP post 
anaesthesia 
0.49" 
-0.34** 
-0.12 
-0.16 
0.05 
0.07 
-0.09 
-0.25 
RPP 
ictal 
-0.06 
0.37" 
0.34" 
0.52* 
0.32* 
0.03 
-0.14 
RPP 
postictal 
0.34" 
0.36" 
0.25 
0.23 
-0.19 
-0.11 
Seizure 
threshold 
0.80" 
-0.33** 
-0.34" 
0.13 
0.56" 
ECT actual 
stimulus dose 
-0.35" 
-0.30* 
0.09 
0.51" 
Motor seizure EEG seizure 
duration duration 
0.89" 
-0.23 -0.09 
-0.40 -0.39" 
Motor seizure 
modification score 
0.18 
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stimulus dose, stimulus laterality, 
postanaesthesia RPP, extent of modification 
scores, EEG and motor seizure durations were 
the independent variables. Postanaesthesia RPP 
(fi=0.54, t=4.9, p=0.001), stimulus laterality 
(fl=-0.37, t=3.4, p=0.01) and motor seizure 
duration (G=0.31, t=2.9, p=0.006) explained 
respectively 24%, 13% and 10% of variance in 
ictal RPP. Unilateral ECT and longer motor 
seizure duration were associated with higher ictal 
RPP. Actual stimulus dose used ((1=0.36, t=2.7, 
p=0.009) explained 13% of variance in postictal 
RPP; higher stimulus was associated with higher 
postictal RPP. Motor seizure modification scores 
(continuous or dichotomous) were not significant 
in both regressions. 
DISCUSSION 
In this study most of the patients with 1 
mg/kg succinylcholine had deeper muscle 
relaxation and good motor seizure modification. 
Succinylcholine being a depolarising muscle 
relaxant, mobilizes intracellular potassium to 
extracellular compartment. Significant increase 
in serum potassium levels from pre- to post- ECT 
occasion was seen only in patients with high' 
dose succinylcholine, which validates the dose 
effect. However none had clinical complications, 
such as cardiac arrhythmia or prolonged apnea. 
Succinylcholine dose used in this study did not 
produce differential cardiovascular responses 
(Table.2). 
Twenty patients had 'poor' motor seizure 
modification. However, modification status did 
not affect RPP measures (Table.2). This 
observation is contrary to the belief that the 
violent seizures may increase myocardial stress. 
Subjects of this study had no cardiovascular 
problems, and were relatively young. Thus 
findings of this study may not apply to elderly or 
cardiac compromised patients. 
.There was no differences in RPP between 
BLECT and ULECT patients receiving 
suprathreshold stimulus. However, Mayur et al. 
(1988a) reported differences between ULECT 
and BLECT patients both receiving threshold 
LI et al. 
stimulus. Similar observations have been 
reported recently (Gangadhar et al.,1999) in an 
intraindividual crossover design. However in the 
multiple regression model, unilateral ECT was 
associated with higher ictal RPP. 
As the dose of succinylcholine and extent 
of motor seizure modification did not influence 
RPP (ictal or postictal), it can be argued that the 
observed effects on RPP were mediated by 
stimulus dose and seizure duration. Thus RPP 
response may be window to cerebral mechanisms 
during ECT. RPP response may hence, be a tool 
to understand the therapeutic or adverse effects 
of ECT. Some trends suggest that higher RPP 
during ECT may be associated with better 
therapeutic potency (Webb et al.,1990). RPP 
holds promise as a noninvasive, but indirect 
measure of CNS effects during ECT to understand 
neurophysiological mechanisms of ECT. 
APPENDIX 
Scale to score extent of motor seizure 
modification. 
(A score of 2 or less indicates poor modification) 
Score Location & intensity of convulsions 
1 Violent convulsions as in unmodified 
ECT 
2 Bilateral motor convulsions and they 
are equal in intensity in both cuffed and 
uncuffed limbs. 
3 Bilateral motor convulsions and the 
intensity is more in cuffed limb when 
compared to corresponding uncuffed 
limb. 
4 Motor convulsions in cuffed limb and 
face. 
5 Motor convulsions only in cuffed limb. 
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